58891-37-5

Basic information

• Product Name: 2-oxo-indan-1-carboxylic acid ethyl ester
• CAS NO: 58891-37-5
• Molecular Weight: 204.225
• Mol File: 58891-37-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-oxo-indan-1-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-oxo-indan-1-carboxylic acid ethyl ester(58891-37-5)
• EPA Substance Registry System: 2-oxo-indan-1-carboxylic acid ethyl ester(58891-37-5)

Safety Data

• Hazardous Substances Data: 58891-37-5(Hazardous Substances Data)

Upstream product

• 17532-66-0 ethyl 2-[2-(2-ethoxy-2-oxoethyl)phenyl]acetate 
• 141-52-6 sodium ethanolate 
• 71-43-2 benzene 
• 613-73-0 1,2-phenylenediacetonitrile 

Downstream Products

• 615-13-4 2-indanone 
• 1126602-63-8 N₄-(4-chloro-2-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-62-7 N₄-(3-chloro-4-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-59-2 N₄-(3-methoxyphenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-58-1 N₄-(4-(trifluoromethyl)phenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-57-0 N₄-(4-bromophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-61-6 N₄-(3-bromophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-56-9 N₄-(4-chlorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-54-7 N₄-(3-chlorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-55-8 N₄-(4-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-53-6 N₄-(3-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-52-5 N₄-(4-isopropylphenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-51-4 N₄-(2-isopropylphenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-60-5 N₄-phenyl-9H-indeno[2,1-d]pyrimidine-2,4-diamine 

Relevant articles and documents

Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents

We designed, synthesized and evaluated 13 novel tricyclic indeno[2,1-d]pyrimidines as RTK inhibitors. These analogues were synthesized via a Dieckmann condensation of 1,2-phenylenediacetonitrile followed by cyclocondensation with guanidine carbonate to af

Benzobicycloalkane ketones

Benzobicycloalkane amines, their pharmacologically acceptable addition salts, intermediates therefore the processes for their preparation and use. The compounds of the invention exert analgesic and anti-inflammatory activity.